The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK WINNERS & LOSERS: Foxtons Falls On London Property Slowdown

Thu, 23rd Oct 2014 10:43

LONDON (Alliance News) - The following stocks are amongst the biggest risers and fallers within the main London indices midday Thursday.
-------
FTSE 100 WINNERS
-------
International Consolidated Airlines Group, up 1.6%. Credit Suisse has added the company to its European Focus List and raised its price target to 616.00 pence from 587.00p, maintaining its Outperform rating. The company currently trades at 377.10p.

GlaxoSmithKline, up 0.8%. Barclays has raised the pharmaceutical giant to Overweight from Equal Weight.

London Stock Exchange Group, up 0.6%. HSBC has raised the company to Overweight from Neutral, with a price target increase to 2,100.00p from 1,861.00p. The stock currently trades at 1,936.00p.
-------
FTSE 100 LOSERS
-------
Tesco, down 5.0%. The supermarket chain said the Deloitte investigation into its overstatement of expected half year profit has been concluded, with the "impact" confirmed as GBP263 million, slightly higher than the GBP250 million it had revealed last month. Of that, GBP118 million related to this year's first-half trading profit, and the rest to prior years. The company added that Chairman Richard Broadbent will step down once the business is "back on track". The news came as it reported a first-half trading profit of just GBP937 million, down 41% on the year before.

Tullow Oil, down 4.3%. The oil & gas producer said it encountered hydrocarbon shows at the Kodos-1 wildcat exploration well in the Kerio Basin onshore Kenya, indicating the presence of an active petroleum system, but reservoirs were mixed quality alluvial sands close to the basin boundary fault at this well location. The company said the Weatherford Rig-804 drilled Kodos-1 to a final depth of 2,500 metres, and the well will be plugged and abandoned. The rig will now be moved to drill the second well in the basin at Epir-1, 25 kilometres north of Kodos-1 in a separate sub-basin. Tullow Oil said further drilling in the greater Kerio Basin can be expected during 2015, following up on the "encouraging" hydrocarbon shows at Kodos-1.

Unilever, down 2.4%. The Anglo-Dutch consumer goods giant reported a further weakening in trading, as market growth continued to slow in emerging markets, particularly in China, and its European markets continued to be hit by volume and price declines. The company said revenue declined 2.0% to EUR12.2 billion in the three months to end-September, with currency movements taking 2.6% off the figure, and following the sale of its North American pasta sauces business and its Slim-Fast brand earlier in the year. Still, the figure was an improvement compared with the first nine months of the year, when revenue declined 4.3% to EUR36.3 billion including a 6.6% currency movement hit. However, underlying sales and volume growth slowed in the third quarter. Underlying sales growth was 2.1%, compared with 3.2% growth for the whole nine months, while volume growth in the quarter was just 0.3%, compared with growth of 1.4% in the first nine months of the year. The CEO warned that the company expects markets to remain tough for at least the remainder of the year, and said it has further accelerated its initiatives to cut costs and simplify the business.

Anglo American, down 2.4%. The miner reported increases in diamond, nickel and iron ore production during the third quarter whilst copper, platinum and thermal coal production declined. The company reported a 37% increase in iron ore production to 13 million tonnes for the third quarter ended September 30, compared to 9.5 million tonnes a year earlier. Iron ore production for the year is expected to reach up to 46 million tonnes, compared to the previous target of 44 million tonnes. It also reported an increase in diamond production to 8.2 million carats in the quarter compared to 7.7 million carats in the third quarter of 2013. Nickel production also rose to 10,700 tonnes from 9,500 tonnes driven by continued improvements at its Barro Alto mine in Brazil. Copper production was down 15% to 176,900 tonnes from 207,300 tonnes a year earlier and platinum production dropped to 533 tonnes in the third quarter from 623 tonnes. Thermal coal dropped to 9 million tonnes, 4% lower than the 9.4 million tonnes reported a year earlier.

Wm Morrison Supermarkets, down 2.0%, and J Sainsbury, down 1.4%. The UK supermarkets are down as a result of Tesco's disappointing full-year results.

BAE Systems, down 1.9%, Smiths Group, down 1.7%, and Intu Properties, down 1.4%. The companies went ex-dividend, meaning new buyers no longer qualify for the latest dividend payouts.

Rio Tinto, down 1.7%. The mining giant said it has extended the tenure of of Chief Executive Sam Walsh and Chief Financial Officer Chris Lynch, saying the move provided a strong endorsement of their leadership, the compay's strategy and its focus on driving shareholder value.
-------
FTSE 250 WINNERS
-------
Debenhams, up 4.9%. The department store operator reported a lower pretax profit for its last financial year, but said the efforts it is taking to turn the business round are paying off as operating profit rose in the second half of the year. Debenhams reported a pretax profit of GBP105.8 million for the 52 weeks to August 30, down from GBP139.0 million a year earlier, as higher sales and distribution costs as well as administrative expenses offset a revenue rise to GBP2.31 billion, from GBP2.28 billion. Its operating profit for the year fell to GBP128.6 million, from GBP155.4 million. However, its operating profit in the second half of the year was up 2.9% on the same period a year earlier, compared with the 22.9% decline it reported in the first half of the year, showing the impact of its turnaround plan, the CEO said. Its gross margin was down 100 basis points in the first half, but was up 10 basis points in the second half.

Inchcape, up 3.5%. The car retailer said it produced a strong performance in the third quarter but said its revenue growth in the period and for the year to date has been hit by the strength of sterling. Inchcape said third quarter revenue was GBP1.7 billion, up 10.6% on a constant currency basis but up only 4.4% at actual currency rates. Like-for-like revenue increased 11.6% at constant currency, but only 6% in actual rates. Sterling strength had a similar impact on its nine-month revenue, up 9.6% at constant currency to GBP5 billion, but up only 1.9% at actual foreign-exchange rates. Like-for-like revenue was up 9.4% at constant rates, but only up 1.9% at actual rates.

Britvic, up 2.8%. The drinks company raised its guidance for full year operating earnings, despite reporting a drop in fourth-quarter revenue, citing poor summer weather and subdued retail spending in Europe. Britvic said it expects earnings before interest and taxes to be ahead of the top end of its GBP148 million to GBP156 million estimate, as revenue and volumes grew over the full year and cost cuts took effect. Still, the company reported a 4% fall in revenue to GBP344.2 million in the fourth quarter, with Ireland sales down 18.5% to GBP33 million and sales in France down 18% to GBP63.8 million. UK sales fell 2.1% to GBP230.1 million while International sales rose 31% to GBP17.3 million.

African Barrick Gold, up 2.1%. The gold miner reported an increase in pretax profit and revenue during the third quarter as higher production rates offset lower gold prices. The company said it delivered its eighth successive quarterly reduction in all-in sustaining costs. It reported a pretax profit of USD45.6 million for the three months ended September 30, compared to USD39.5 million in the comparable period in 2013. For the nine months ended September 30, African Barrick have reported a pretax profit of USD107.8 million, compared to the USD817 million loss reported a year earlier. Revenue for the quarter increased to USD240.9 million, compared to USD220 million in the comparable period in 2013. For the first three quarters of the year, African Barrick has generated USD686.4 million in revenue, compared to USD707.4 million in 2013. Higher sales volumes helped offset the lower gold prices, it said.

SEGRO, up 1.5%. The property company said it made good progress in the third quarter on the back of stronger occupational market conditions in the UK. SEGRO said it added GBP1.9 million in annualised net rent in the quarter to the end of September, against a GBP0.1 million net take-back in the same period last year. The group let 149,000 square metres of existing space in the quarter.

SVG Capital, up 1.0%. The private equity investor said it expects to complete the return of GBP470 million to shareholders by the end of the first quarter of 2015, having returned GBP390 million to date. In a third-quarter statement, SVG Capital outlined plans for a tender offer of up to GBP50 million in December, with pricing to be determined with reference to share price and net asset value per share. The company said the "relatively buoyant" exit environment over the last few years has allowed it to return a significant amount of capital to shareholders.
-------
FTSE 250 LOSERS
-------
Foxtons Group, down 16%. The estate agency said its third-quarter performance had been hit by a sharp slowdown in London property sales volumes over the period, adding its expectation that market volumes will remain constrained for the second half has forced it to downgrade its earnings forecast for the year. The company said its performance in the third quarter to September 30 was hit by a slowdown in London property sales, coming after an "exceptionally strong" period in the nine months to June 30, when it said volumes hit the highest levels since 2007. It said market volumes in the third quarter were more in line with the first half of 2013 and said it now expects the second half of 2014 to see a significant fall in volumes year-on-year. Group revenue for the third quarter was down to GBP39.9 million from GBP41.1 million a year earlier. Revenue for the nine months to September 30 remains above the year before, at GBP112.7 million against GBP103.7 million in 2013.

Ladbrokes, down 4.0%. The bookmaker said it is on track to meet full-year expectations and reaffirmed its dividend plans after posted a jump in operating profit and a rise in revenue in the third quarter. The company said group operating profit in the third quarter to September 30 was GBP33 million, nearly double the GBP17 million posted a year earlier. That came on the back of a 13% rise in net revenue in the period, it said. However, Numis has reiterated its Reduce rating on the stock, saying that upcoming regulation in the gambling industry will weigh on the company's future profits.

IG Group Holdings, down 2.8%. The company is amongst the fallers in the mid-cap index after going ex-dividend.

Hochschild Mining, down 2.5%. The precious metal miner reported a drop in third-quarter production, but said it remains on track to meet is full-year output expectations and will continue to cut costs. Attributable production fell to 4.8 million silver equivalent ounces in the three months to September 30, from 6.3 million ounces a year earlier and from 5.9 million ounces in the second quarter. The company's silver production fell to 3.5 million ounces and gold production fell to 21 million ounces.
-------
AIM ALL-SHARE WINNERS
-------
StratMin Global Resources, up 17%. The company said it had identified substantial surficial regolith-hosted graphite mineralisation at its Mahefadok prospect, in the central part of the Loharano property in Madagascar about 1,500 metres south-east of its producing Loharano graphite deposit. StratMin said geophysical surveying, geological mapping and the excavation of forty pits and four trenches at the site identified mineralisation that occurs as two north-south zones 250 and 750 metres in length, between 70 and 120 metres in width and up to 5.90 metres in depth, the maximum depth of excavations.

Baron Oil, up 8.7%. The company said it has obtained approval in Peru to move to a drilling programme at the Block Z-34 well and said studies conducted on the Block XXI area in Peru showed significantly higher hydrocarbon potential than previously thought. Baron said it and its partner, Union Oil and Gas Group Corp, have obtained approval from Perupetro SA, the Peruvian state oil company, to start a drilling programme at the Block Z-34 site. Perupetro also approved a Force Majeure clause for the block, extending the time limit for the well to be drilled. In addition, the company said the results from the Block XXI prospect showed significant higher hydrocarbon potential in the areas than previously understood. On the back of the strong results, Baron is planning to acquire 600 km of 2D seismic in the southern area of the block in the early part of 2015.

Porta Communications, up 7.1%. The company said trading in the third quarter was strong, with all of its operating units hitting targets, and it is in talks about possible acquisitions that could further boost profitability. The group's Newgate Communications business in the UK won 15 new clients and projects in the quarter, while its Redleaf PR arm, acquired in April this year, is trading ahead of budget with a regular flow of new business, it said. Porta also said it is in advanced talks on two potential acquisitions which, if completed, are expected to have an impact on both its trading and profitability levels.
-------

By Neil Thakrar; neilthakrar@alliancenews.com

Copyright 2014 Alliance News Limited. All Rights Reserved.

More News
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 17:08

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies will urge a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more
22 Jan 2024 09:34

IN BRIEF: Oxford Nanopore appoints Keher to CFO as Cowper becomes COO

Oxford Nanopore Technologies - Oxford, England-based company specialising in nanopore DNA-sequencing - Appoints Nick Keher as chief financial officer and director, effective immediately. Keher will replace Tim Cowper as he moves into a new role as Oxford Nanopore's chief operating officer. The company says that Cowper has been performing the majority of COO duties for the past five years, and that he will lead the company's efforts to expand its international footprint. The company also says that new CFO Keher possesses "significant experience of financial leadership of complex, scientific businesses", having served in similar roles at Clinigen Group PLC, BenevolentAI SA, Royal Bank of Canada, Investec PLC and GSK PLC.

Read more
17 Jan 2024 09:38

UPDATE: GSK raises GBP978 million as cuts stake in Haleon to 4.2%

(Alliance News) - GSK PLC early Wednesday confirmed it agreed to sell 300 million shares in Haleon PLC, reducing its remaining stake in the consumer healthcare products spin-off to just 4.2%.

Read more
17 Jan 2024 08:05

GSK raises £978m through Haleon share sale

(Sharecast News) - GSK said on Wednesday that it has raised around £978m from the sale of shares in Haleon.

Read more
17 Jan 2024 07:46

LONDON BRIEFING: UK inflation surprises as unexpectedly rises to 4.0%

(Alliance News) - Stocks in London are called to open lower on Wednesday, following some hotter-than-expected consumer price data from the UK.

Read more
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.